DENTSPLY SIRONA Inc
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
XRAY$9.70+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
(in millions)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $17 | $(23) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Depreciation | 32 | 31 |
| Amortization of intangible assets | 54 | 53 |
| Fixed asset impairment | — | 4 |
| Indefinite-lived intangible asset impairment | 6 | — |
| Deferred income taxes | (9) | (21) |
| Stock based compensation expense | 11 | 17 |
| Restructuring and other costs | — | 48 |
| Other non-cash expense | 19 | 9 |
| Changes in operating assets and liabilities, net of acquisitions: | ||
| Accounts and notes receivable-trade, net | 27 | (15) |
| Inventories, net | (5) | (30) |
| Prepaid expenses and other current assets | (28) | (17) |
| Other noncurrent assets | (6) | (1) |
| Accounts payable | (28) | (14) |
| Accrued liabilities | (50) | (31) |
| Income taxes | (2) | (37) |
| Other noncurrent liabilities | (13) | 6 |
| Net cash provided by (used in) operating activities | 25 | (21) |
| Cash flows from investing activities: | ||
| Capital expenditures | (34) | (39) |
| Cash received on derivative contracts | — | 2 |
| Cash paid on derivative contracts | (9) | — |
| Net cash used in investing activities | (43) | (37) |
| Cash flows from financing activities: | ||
| Cash paid for treasury stock | — | (150) |
| Proceeds on short-term borrowings | 23 | 198 |
| Cash dividends paid | (29) | (27) |
| Repayments on long-term borrowings | (3) | — |
| Other financing activities, net | (5) | (4) |
| Net cash (used in) provided by financing activities | (14) | 17 |
| Effect of exchange rate changes on cash and cash equivalents | (11) | (6) |
| Net decrease in cash and cash equivalents | (43) | (47) |
| Cash and cash equivalents at beginning of period | 334 | 365 |
| Cash and cash equivalents at end of period | $291 | $318 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.